Condition
Ototoxicity, Drug-Induced clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Ototoxicity, Drug-Induced clinical trials that are recruiting, at sites in 4 countries (most in United States (1), Germany (1), Thailand (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Ototoxicity, Drug-Induced clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| N-acetylcysteine to prevent cisplatin-related hearing loss | Phase 2 | Bangkok, Bangkoknoi | Recruiting | Jan 23, 2026 |
| Cisplatin-related (Ear) Hearing Loss and Balance Issues in Head and Neck Cancer Patients | — | Nuremberg, Bavaria | Recruiting | Apr 16, 2025 |
| Assessing hearing loss caused by cancer treatments | — | Paris | Recruiting | Jul 8, 2024 |
| Preventing hearing loss in patients with NTM treated with amikacin | Phase 2 | San Francisco, California and 7 other locations | Recruiting | Feb 15, 2023 |
All recruiting trials (4)
-
N-acetylcysteine to prevent cisplatin-related hearing loss
This study tests whether N-acetylcysteine (NAC) can prevent hearing loss in adults receiving high-dose cisplatin chemotherapy.
-
Cisplatin-related (Ear) Hearing Loss and Balance Issues in Head and Neck Cancer Patients
This observational study tests whether hearing loss, tinnitus, and balance problems occur in head and neck cancer patients treated with cisplatin chemoradiotherapy compared with those receiving only radiotherapy, including optional genetic tests for susceptibility.
-
Assessing hearing loss caused by cancer treatments
This study is testing how certain cancer treatments might affect hearing and balance in cancer patients and healthy volunteers by doing regular hearing tests.
-
Preventing hearing loss in patients with NTM treated with amikacin
This study is testing whether a new drug called ORC-13661 can help prevent hearing loss in patients with nontuberculous mycobacterial infections who are being treated with amikacin.
Related topics
Quick answers
How many Ototoxicity, Drug-Induced clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (1 trial), Germany (1 trial), Thailand (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.